XML 28 R17.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Information
 3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION
As previously disclosed, effective December 31, 2021 we changed our reportable business segments to (i) MedSurg and Neurotechnology and (ii) Orthopaedics and Spine to align to our new internal reporting structure.
Three Months
20222021
MedSurg and Neurotechnology$2,423 $2,191 
Orthopaedics and Spine1,852 1,762 
Net sales$4,275 $3,953 
MedSurg and Neurotechnology$611 $635 
Orthopaedics and Spine522 455 
Segment operating income$1,133 $1,090 
Items not allocated to segments:
Corporate and other
$(199)$(162)
Acquisition and integration-related costs(149)(249)
Amortization of intangible assets
(150)(181)
Restructuring-related and other charges
(109)(14)
Medical device regulations
(28)(19)
Recall-related matters
(14)(6)
Regulatory and legal matters
(37)— 
Consolidated operating income$447 $459 
There were no significant changes to total assets by segment from information provided in our Annual Report on Form 10-K for 2021, other than the addition of the assets acquired in the Vocera acquisition which are included in the MedSurg and Neurotechnology segment.